Dr. Snyder is the Director, Medical and Scientific Relations, at the Alzheimer’s Association. She oversees the Association's International Research Grant Program, the mechanism through which the Association funds research applications. In addition to ensuring the smooth review of applications and distribution of awards to successful applicants, she is responsible for the dissemination of results and ongoing investigations to a wide range of audiences.
Dr. Snyder oversees the Association’s participation in the Everyday Technology in Alzheimer’s Care initiative, which is a joint effort with Intel that brings together technology researchers who are working to improve quality of life for people affected by Alzheimer's and their caregivers.
She also manages a collaborative project with the National Institute on Aging of the National Institutes of Health to develop a Common Alzheimer’s Disease Research Ontology (CADRO) to
enable the integration and comparative analysis of Alzheimer’s research portfolios from public and private organizations in the U.S. and abroad.
Dr. Snyder received her Ph.D. from Loyola University Chicago Stritch School of Medicine and her B.A. in Biology and Religious Studies from The University of Virginia. Since graduating from
Stritch, she completed a postdoctoral fellowship in the Neurobiology Program at Children’s Memorial Research Center, affiliated with Northwestern University, in Chicago. During this time, she received a training fellowship from the National Institutes of Health, published papers related to mechanisms of neuronal toxicity in neurodegenerative diseases including Parkinson’s disease and Alzheimer's disease, and presented topics related to areas of research in both national and international venues.
The Alzheimer’s Association is the leading voluntary health organization in Alzheimer’s care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s disease.